← SynDRA
GLYCEROL PHENYLBUTYRATE
SynDRA canonical compound SYN0031605 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CYP3A5 | TMEM97 |
|---|
| Mechanism of action | sigma receptor ligand |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Antimetabolites
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Noxae
- Ammonium Ion Binding Activity
- Nitrogen Binding Agent
ATC classes
- A16A · OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
Cross-references
Synonyms
- RAVICTI
- Ravicti
- ravicti
- HPN-100
- Phenylbutyrate de glycerol
- Fenilbutirato de glicerol
- HPN100
- GT4P
- Glyceryl tri-(4-phenylbutyrate)
- ZH6F1VCV7B
- Propane-1,2,3-triyl tris(4-phenylbutanoate)
- BENZENEBUTANOIC ACID, 1,2,3-PROPANETRIYL ESTER
- HPN 100
- TRI(4-PHENYLBUTYRYL)GLYCEROL
- GLYCERYL TRI (4-PHENYLBUTYRATE)
- GLYCERYL TRI(4-PHENYLBUTYRATE)
- fenilbutirato de glicerol
- phenylbutyrate de glycerol
- glyceroli phenylbutyras
- RefChem:55276
- A16AX09
- DTXCID00132496
- Glycerolphenylbutyrate
- UNII-ZH6F1VCV7B
- Tris(4-phenylbutyryl)glycerol
- Glyceryl Tri-4-Phenylbutyrate
- Tri(4-phenylbutyryl) Glycerol
- Glycerol phenylbutyrate [USAN]
- Glycerol phenylbutyrate [USAN:INN]
- Ravicti (TN)
- orb1308269
- SCHEMBL10102804
- HY-B2087R
- CHEBI:134745
- Glycerol phenylbutyrate (Standard)
- HMS5087F05
Reported adverse events
- Abdominal discomfort
- Dizziness
- Dysgeusia
- Fatigue
- Flatulence
- Decreased appetite
- Abdominal pain
- Dyspepsia
- Headache
- Nausea
- Neurotoxicity
- Vomiting
Look up GLYCEROL PHENYLBUTYRATE in the interactive SynDRA portal →